Company / Operating Income
Bruker Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$68.2M
FY2025
5-year range
$68.2M / $436.9M
FY2021-FY2025
Trend
-73.1%
vs FY2024
Sector context
#76 of 151
Health Care
What the data says
At $68M, Bruker's operating income ranks #76 of 151 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from $68M in FY2025 to $437M in FY2023.
Based on SEC 10-K filings.
$68M in FY2025 with a 5-year CAGR of -22.8%.
Declined from $437M to $68M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -46.0%
- 5-Year CAGR
- -22.8%
- 10-Year CAGR
- -
Sector benchmark
#76 of 151 in Health CareTop 50% of 151This company $68.2M Sector average $716.7M
▼
-90.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -22.8%, indicating a declining trend.
- In FY2025, operating income decreased 73.1% year-over-year.
- Ranks #76 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2023.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.2M | -73.1% |
| FY2024 | $253.1M | -42.1% |
| FY2023 | $436.9M | +1.0% |
| FY2022 | $432.7M | +4.7% |
| FY2021 | $413.3M | +66.5% |
| FY2020 | $248.3M | -17.5% |
| FY2019 | $300.9M | +14.7% |
| FY2018 | $262.4M | +19.5% |
| FY2017 | $219.5M | +20.7% |
| FY2016 | $181.8M | +24.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026